Clinical trial
Prophylactic Urethral Stenting With Memokath After Prostate Implantation for…
NCT00252941 · The Cleveland Clinic, Other · Completed
Key facts
| NCT number | NCT00252941 |
|---|---|
| Title | Prophylactic Urethral Stenting With Memokath After Prostate Implantation for Prostate Adenocarcinoma |
| Official title | The Role Of Prophylactic Urethral Stenting With Memokath® 028SW in Patients Undergoing Prostate 125I Seed Implants For Prostate Carcinoma: A Phase I/II Study |
| Lead sponsor | The Cleveland Clinic, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer, Post-Brachytherapy Bladder Outlet Obstruction |
| Intervention type | Device |
| Interventions | Memokath 028SW Urethral Stent |
| Enrollment | 20 |
| Start date | Nov 1, 2005 |
| Primary completion | Apr 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Nov 15, 2005 |
| Last update posted | Dec 21, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: